Hayley M. McDaid

2.4k citations

34 papers · 1.9k indexed · 1 hit paper · h-index 20

Co-authors: Susan Band Horwitz Pascal Verdier‐Pinard George A. Orr Alicia Rodriguez‐Gabin Eleni Andreopoulou Lluís López-Barcons Amos B. Smith P. G. Johnston
Topics: Microtubule and mitosis dynamics (14 papers)Cancer Treatment and Pharmacology (14 papers)Melanoma and MAPK Pathways (6 papers)
Cited by: Cell Biology Oncology Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations: United States United Kingdom Switzerland

In The Last Decade

Hayley M. McDaid

34 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanisms of Taxol resistance related to microtubules

2003 563 citations George A. Orr, Pascal Verdier‐Pinard et al. Oncogene profile →

Peers

Countries citing papers authored by Hayley M. McDaid

Since Specialization

Citations

This map shows the geographic impact of Hayley M. McDaid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hayley M. McDaid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hayley M. McDaid more than expected).

Fields of papers citing papers by Hayley M. McDaid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hayley M. McDaid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hayley M. McDaid. The network helps show where Hayley M. McDaid may publish in the future.

Co-authorship network of co-authors of Hayley M. McDaid

This figure shows the co-authorship network connecting the top 25 collaborators of Hayley M. McDaid. A scholar is included among the top collaborators of Hayley M. McDaid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hayley M. McDaid. Hayley M. McDaid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural Refinement of the Tubulin Ligand (+)-Discodermolide to Attenuate Chemotherapy-Mediated Senescence 2020 ·Molecular Pharmacology ·(unknown),Alicia Rodriguez‐Gabin,A.E. Prota,Tobias Mühlethaler,Nan Zhang,Kenny Ye,Michel O. Steinmetz,Susan Band Horwitz,Amos B. Smith,Hayley M. McDaid	5
2	Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin 2018 ·SHILAP Revista de lepidopterología ·Adam Friedman,Kenny Ye,Alicia Rodriguez‐Gabin,(unknown),Joel M. Friedman,Alan Alfieri,(unknown),Angelo Landriscina,Jamie Rosen,David Schairer,(unknown),(unknown),Aimee E. Krausz,Hayley M. McDaid	8
3	Therapeutic Advances and New Directions for Triple-Negative Breast Cancer 2017 ·Breast Care ·Eleni Andreopoulou,Catherine M. Kelly,Hayley M. McDaid	33
4	A Novel Indication for Panobinostat as a Senolytic Drug in NSCLC and HNSCC 2017 ·Scientific Reports ·(unknown),(unknown),Alicia Rodriguez‐Gabin,Hayley M. McDaid	135
5	Defining optimal combinations of PI3K/Akt/mTOR and Ras/Raf/MAPK pathway inhibitors for use in endometrial cancer 2014 ·Gynecologic Oncology ·(unknown),Alicia Rodriguez‐Gabin,Gary L. Goldberg,Susan Band Horwitz,Hayley M. McDaid	2
6	Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma 2013 ·PLoS ONE ·June Y. Hou,Alicia Rodriguez‐Gabin,(unknown),Rachel B. Hazan,Gary L. Goldberg,Susan Band Horwitz,Hayley M. McDaid	22
7	N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties 2013 ·Oncogene ·Xia Qian,(unknown),(unknown),K Suyama,(unknown),James Hulit,Georgia Agiostratidou,(unknown),Hayley M. McDaid,Chandandeep Nagi,Hillel W. Cohen,Greg R. Phillips,Larry Norton,Rachel B. Hazan	103
8	Characterization of a human βV‐tubulin antibody and expression of this isotype in normal and malignant human tissue 2012 ·Cytoskeleton ·(unknown),Yihong Wang,Pascal Verdier‐Pinard,Chia‐Ping Huang Yang,Lingling Liu,Alicia Rodriguez‐Gabin,Hayley M. McDaid,Susan Band Horwitz	9
9	High Expression of Class III β-Tubulin Predicts Good Response to Neoadjuvant Taxane and Doxorubicin/Cyclophosphamide-Based Chemotherapy in Estrogen Receptor–Negative Breast Cancer 2012 ·Clinical Breast Cancer ·Yihong Wang,Joseph A. Sparano,Susan Fineberg,(unknown),(unknown),Susan Band Horwitz,Hayley M. McDaid	26
10	Antitumor Activity of Vinflunine: Effector Pathways and Potential for Synergies 2008 ·Seminars in Oncology ·Diane Braguer,(unknown),Hayley M. McDaid,Anna Kruczynski	18
11	Targeting Protein Translation in Human Non–Small Cell Lung Cancer via Combined MEK and Mammalian Target of Rapamycin Suppression 2007 ·Cancer Research ·(unknown),Chia‐Ping Huang Yang,(unknown),Lluís López-Barcons,Steven M. Keller,Román Pérez-Soler,Susan Band Horwitz,Hayley M. McDaid	66
12	Potentiation of Taxol Efficacy by Discodermolide in Ovarian Carcinoma Xenograft-Bearing Mice 2006 ·Clinical Cancer Research ·Gloria S. Huang,Lluís López-Barcons,B. Scott Freeze,Amos B. Smith,Gary L. Goldberg,Susan Band Horwitz,Hayley M. McDaid	60
13	Enhancement of the Therapeutic Efficacy of Taxol by the Mitogen-Activated Protein Kinase Kinase Inhibitor CI-1040 in Nude Mice Bearing Human Heterotransplants 2005 ·Cancer Research ·Hayley M. McDaid,Lluís López-Barcons,Aaron Grossman,Marie Lia,Steven M. Keller,Román Pérez-Soler,Susan Band Horwitz	72
14	Mechanisms of Taxol resistance related to microtubulesbreakdown → 2003 ·Oncogene ·George A. Orr,Pascal Verdier‐Pinard,Hayley M. McDaid,Susan Band Horwitz	563
15	Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a phase I clinical study. 2002 ·PubMed ·Hayley M. McDaid,Sridhar Mani,(unknown),Franco M. Muggia,Daryl Sonnichsen,Susan Band Horwitz	78
16	Selective Potentiation of Paclitaxel (Taxol)-Induced Cell Death by Mitogen-Activated Protein Kinase Kinase Inhibition in Human Cancer Cell Lines 2001 ·Molecular Pharmacology ·Hayley M. McDaid,Susan Band Horwitz	1
17	Selective Potentiation of Paclitaxel (Taxol)-Induced Cell Death by Mitogen-Activated Protein Kinase Kinase Inhibition in Human Cancer Cell Lines 2001 ·Molecular Pharmacology ·Hayley M. McDaid,Susan Band Horwitz	100
18	Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines. 2000 ·PubMed ·Laura Martello,Hayley M. McDaid,(unknown),(unknown),Dong‐Fang Meng,Thomas R. R. Pettus,Michael D. Kaufman,Hirokazu Arimoto,Samuel J. Danishefsky,Amos B. Smith,Susan Band Horwitz	133
19	Increased expression of the RIα subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer 1999 ·British Journal of Cancer ·Hayley M. McDaid,Michael T. Cairns,R. Atkinson,(unknown),D. Paul Harkin,Paula M. Gilmore,P. G. Johnston	58
20	Structure-activity profiles of eleutherobin analogs and their cross-resistance in Taxol-resistant cell lines 1999 ·Cancer Chemotherapy and Pharmacology ·Hayley M. McDaid,Samit K. Bhattacharya,(unknown),Lifeng He,(unknown),Clare E. Gutteridge,Susan Band Horwitz,Samuel J. Danishefsky	31

About Hayley M. McDaid

Hayley M. McDaid is a scholar working on Cell Biology, Oncology and Molecular Biology, having authored 34 papers that have together received 1.9k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (14 papers), Cancer Treatment and Pharmacology (14 papers) and Melanoma and MAPK Pathways (6 papers). The work is most often cited by research in Cell Biology (572 citations), Oncology (916 citations) and Molecular Biology (1.1k citations). Hayley M. McDaid has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Susan Band Horwitz, Pascal Verdier‐Pinard, George A. Orr, Alicia Rodriguez‐Gabin, Eleni Andreopoulou, Lluís López-Barcons, Amos B. Smith, P. G. Johnston, Sridhar Mani and Franco M. Muggia. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact